详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ 统计源期刊 ◇ 中华系列

作者：

机构： [1]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China [2]Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China [3]Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China [4]Beijing Tongren Hosp, Dept Endocrinol, Beijing 100730, Peoples R China [5]Wuhan Union Hosp, Dept Endocrinol, Wuhan 430022, Hubei, Peoples R China [6]Shanghai Changzheng Hosp, Dept Endocrinol, Shanghai 200003, Peoples R China [7]Tianjin Med Univ, Dept Endocrinol, Metab Dis Hosp, Tianjin 300070, Peoples R China [8]Zhongshan Univ, Dept Endocrinol, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China

出处：

DOI：

ISSN：

关键词： biphasic insulin aspart 30 diabetes mellitus type 2 weight gain hypoglycaemia China

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2008]版：

大类 | 4 区医学

小类 | 4 区医学：内科

最新[2025]版：

大类 | 2 区医学

小类 | 2 区医学：内科

JCR分区：

出版当年[2007]版：

Q3 MEDICINE, GENERAL & INTERNAL

最新[2023]版：

Q1 MEDICINE, GENERAL & INTERNAL

影响因子： 7.5 最新[2023版] 4.9 最新五年平均 0.636 出版当年[2007版] 0.685 出版当年五年平均 0.615 出版前一年[2006版] 0.858 出版后一年[2008版]

第一作者：

第一作者机构： [1]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes [2]Thrice-daily biphasic insulin aspart 30 is more effective and as safe as a twice-daily regimen in subjects with type 2 diabetes inadequately controlled with OADs [3]HEALTH CARE UTILIZATIONS AND COSTS OF INSULIN PATIENT-DRIVEN TITRATION VERSUS PHYSICIAN-DRIVEN TITRATION: EVIDENCE BASED ON A CLINICAL TRIAL OF BIPHASIC INSULIN ASPART 30 TWICE DAILY IN PEOPLE WITH TYPE 2 DIABETES IN CHINA [4]门冬胰岛素30注射液治疗糖尿病的疗效及安全性比较：多中心、随机、开放、对照研究 [5]The Prevalence and Causes of Visual Impairment in Type 2 Diabetes Mellitus in Northeast China [6]每日三次注射双时相门冬胰岛素(biasp50-50-30)与每日两次注射双时相门冬胰岛素30均联合二甲双胍对2型糖尿病患者的疗效和安全性比较的研究 [7]Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs [8]Clinical Analysis of Elderly Patients with Elderly-onset Type 2 Diabetes Mellitus in China: Assessment of Appropriate Therapy [9]Relationships of angiotensinogen gene M235T variant with diabetic nephropathy in Chinese type 2 diabetes mellitus [10]Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study